The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 2,004.00
Ask: 2,006.00
Change: 13.00 (0.66%)
Spread: 2.00 (0.10%)
Open: 1,987.00
High: 2,008.00
Low: 1,979.00
Prev. Close: 1,981.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 17th Jul 2014 11:07

Antofagasta: Canaccord Genuity cuts target price from 870p to 835p and maintains a hold recommendation.African Minerals: Canaccord Genuity reduces target price from 230p to 170p and keeps a buy recommendation.Ashmore Group: Goldman Sachs downgrades to neutral with a target price of 430p.Barclays: Exane reduces target price from 280p to 225p retaining a neutral rating.BHP Billiton: Goldman Sachs lowers target price from 1820p to 1810p retaining its neutral rating. Canaccord Genuity reduces target price from 2100p to 1935p and keeps a hold recommendation.Big Yellow Group: Morgan Stanley raises target price from 445p to 615p and upgrades from equal-weight to overweight.Central Asia Mining: Canaccord Genuity lowers target price from 200p to 190p retaining its buy recommendation.City of London Investment Group: N+1 Singer raises target price from 220p to 317p and upgrades to buy.Croda International: Barclays reduces target price from 2330p to 2100p and downgrades from equal-weight to underweight.Diageo: JP Morgan cuts target price from 1780p to 1760p and downgrades from neutral to underweight.Drax Group: Citi cuts target price from 750p to 700p downgrading from buy to neutral.EMIS: Panmure Gordon moves target price from 851p to 858p keeping a buy recommendation. N+1 Singer moves target price from 820p to 830p and retains a buy recommendation.International Ferro Metal: Numis places both its target price and its buy recommendation under review.Fesnillo: Deutsche Bank takes target price from 870p to 890p and maintains a hold recommendation. JP Morgan ups target price from 1030p to 1100p and retains an overweight rating.Friends Life Group: Berenberg ups target price from 310p to 330p and keeps a hold recommendation.Gable Holdings: Panmure Gordon moves target from 92p to 105p and retains a buy recommendation.Genel Energy: Canaccord Genuity reduces target price from 1230p to 1100p, while its buy recommendation remains kept.Glencore Xstrata: Goldman Sachs shifts target price from 295p to 300p and stays with its neutral rating.Greene King: JP Morgan reduces target price from 940p to 890p leaving its neutral rating unaltered.Gulf Keystone: Canaccord Genuity shifts target price from 95p to 100p and keeps a hold recommendation.Hikma Pharmaceuticals: UBS raises target price from 1700p to 2000p and upgrades from neutral to buy.Hilton Food Group: Numis cuts target price from 610p to 592p and retains an add rating.ICAP: UBS lowers target price from 330p to 320p and keeps a sell recommendation. Citi cuts target price from 385p to 370p and leaves its neutral rating unchanged.ITV: Investec places both its target price (prev.: 195p) and its hold recommendation under review.Judges Scientific: WH Ireland reduces target price from 2370p to 1550p and stays with its neutral rating.Kazakhmys: Canaccord Genuity shifts target price from 260p to 265p, while downgrading from hold to sell.Lancashire: JP Morgan cuts target price from 744p to 725p and stays with its neutral rating.Oxford Instruments: N+1 Singer reduces target price from 1445p to 1350p and maintains a hold recommendation.Phoenix Group Holdings: Berenberg upgrades from hold to buy with a target price of 750p.Rexam: Deutsche Bank ups target price from 550p to 570p, while downgrading from buy to hold.Ricardo: Oriel places both its target price (prev.: 670p) and its reduce rating under review.Rio Tinto: Goldman Sachs lowers target price from 2530p to 2520p reiterating its strong sell recommendation. JP Morgan ups target price from 4100p to 4150p and stays with its overweight rating. Canaccord Genuity cuts target price from 4200p to 4145p and reiterates a buy recommendation.Royal Mail: Deutsche Bank reduces target price from 587p to 486p and retains a hold recommendation. JP Morgan cuts target price from 765p to 745p and stays with an overweight rating.Thomas Cook Group: Numis reduces target price from 175p to 135p and maintains its hold recommendation.Trinity Exploration & Production: Investec places its target price (prev.: 250p) under review, while keeping a buy recommendation.Tullow Oil: Canaccord Genuity reduces target price from 950p to 850p and stays with its hold recommendation.Weatherly International: Canaccord Genuity lowers target price from 6p to 5p and keeps its buy recommendation.
More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.